Latest Earnings Results: Q2 '26
Estimated EPS
$2.01
Reported EPS
$2.07
Surprise
+2.97%
Estimated Rev
$2.13B
Reported Rev
$2.18B
Surprise
+1.97%
• Reported GAAP EPS of $1.03 up 33.77% YoY • Reported revenue of $2.18B up 4.80% YoY • Zimmer Biomet Holdings, Inc. updated its full-year 2026 guidance, raising reported revenue growth to 3.9%-4.9% and adjusted diluted EPS to a range of $8.47-$8.59, reflecting confidence in its ongoing business momentum.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $1.88 | -- | -- | N/A |
Q2 '26 | $2.01 | $2.07 | 2.97% | BEAT |
Q1 '26 | $1.87 | $2.09 | 12.05% | BEAT |
Q4 '25 | $2.40 | $2.42 | 0.92% | BEAT |
Q3 '25 | $1.87 | $1.90 | 1.82% | BEAT |